Cafepharma Today

April 17 2024 - Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study
3 patent expirations in 2024 and how companies are pivoting
Abbott beats Wall Street expectations with med device sales, raises outlook
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche's Pain May Be Merck's Gain
Seeking Alpha
Monday, May 7, 2012 - 11:16am
tags:
Roche, Merck, dalcetrapib, Abbott Laboratories, Bristol-Myers Squibb, Gilead, Eli Lilly, Pfizer, Sanofi, Illumina
Eli Lilly's Valuation May Prove To Be A Good Investment Opportunity
Seeking Alpha
Monday, May 7, 2012 - 11:13am
tags:
Eli Lilly, Amylin, GSK, Novo Nordisk, Pfizer, Sanofi
Pfizer Arthritis Pill Raises Safety Concerns, FDA Staff Says
Bloomberg
Monday, May 7, 2012 - 11:12am
tags:
Pfizer, tofacitinib, rheumatoid arthritis, FDA
Apricus Biosciences granted pre-NDS meeting for Femprox
Yahoo/Fly on the Wall
Monday, May 7, 2012 - 11:11am
tags:
Apricus Biosciences, Femprox, Canada
Ardea Biosciences Announces First Quarter 2012 Financial Results
Yahoo
Monday, May 7, 2012 - 10:59am
tags:
Ardea, earnings
Roche Drops After Halting Cholesterol Drug Development
Bloomberg
Monday, May 7, 2012 - 10:58am
tags:
Roche, dalcetrapib
Rolling Gilead Protected Covered Call For Additional Potential Profit
Seeking Alpha
Sunday, May 6, 2012 - 11:53am
tags:
Gilead Sciences
Why It Is Teva Time
Seeking Alpha
Sunday, May 6, 2012 - 11:47am
tags:
Teva Pharmaceuticals
Latuda (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia
Enhanced Online News
Sunday, May 6, 2012 - 11:45am
tags:
Latuda, schizophrenia, Sunovion
Incyte looks to ride on drug's success
The News Journal, DE
Sunday, May 6, 2012 - 11:44am
tags:
Incyte, Jakafi, myelofibrosis, polycythemia
Teva Nearly 40% Undervalued, Merits 'Strong Buy'
Seeking Alpha
Sunday, May 6, 2012 - 11:40am
tags:
Teva Pharmaceuticals
Biotech Takeovers: Who's Next On The Block?
Seeking Alpha
Sunday, May 6, 2012 - 11:34am
tags:
Gilead Sciences, Amylin, Vivus, Vertex Pharmaceuticals, BioSante, Dendreon
Bayer appeals India patent office ruling
MarketWatch
Saturday, May 5, 2012 - 4:58pm
tags:
Bayer, patents, Nexavar, generics
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
PharmiWeb
Saturday, May 5, 2012 - 4:54pm
tags:
Tavaborole, Anacor, AN2728, atopic dermatitis, Onychomycosis, antifungals
Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Pharmabiz
Saturday, May 5, 2012 - 4:38pm
tags:
Pfizer, Quark Pharmaceuticals, Silence Therapeutics, PF-655, Open-Angle Glaucoma, diabetic macular oedema, AtuRNAi
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Pharmalive
Saturday, May 5, 2012 - 4:33pm
tags:
Valeant Pharmaceuticals, AcneFree, University Medical
Phase I trial of novel HER2/neu Antigens will Start at Mayo; Isis Initiates Phase 2 Study of ISIS-APOCIIIRx
BioMedReports
Saturday, May 5, 2012 - 4:31pm
tags:
TapImmune, HER-2/neu vaccine, vaccines, Isis Pharmaceuticals, ISIS-APOCIIIRx, hypertriglyceridemia
Teva to Present New Data on Women's Health Products at the American Congress of Obstetricians and Gynecologists Annual Clinical Meeting
Sacramento Bee, CA
Saturday, May 5, 2012 - 2:14pm
tags:
Teva Pharmaceuticals, Plan B contraceptive, contraceptives
Apricus Biosciences Announces Poster Presentation of Femprox Phase III Clinical Data at American Urological Association Annual Meeting
Pharmalive
Saturday, May 5, 2012 - 2:12pm
tags:
Femprox, Apricus Biosciences, female sexual dysfunction
Pharma startup led by Lilly Ventures execs raises $4.6 million
MedCity News
Saturday, May 5, 2012 - 2:11pm
tags:
Esanex Inc, Lilly Ventures

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels
Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)
Drug Channels

Latest Jobs

Pharmaceutical Sales- Associate Territory Manager- Primary Care
Washington DC, 20066
Eli Lilly and Company
Sales Representative
Nampa, ID, 83651
Bartlett Roofing
Pharmaceutical Sales Representative (PSR)
Iowa City, IA, 52246
Syneos Health, Inc
Diagnostics Hematology Specialist (Michigan)
Michigan, ND, 58259
Adaptive Biotechnologies
Professional Pharmaceutical Sales Representative
Pueblo, CO, 81001
Syneos Health, Inc
Pharmaceutical Sales- Associate Territory Manager- Primary Care
Covington, Georgia
Eli Lilly and Company
Manager, Inside Sales
Austin, TX
AbbVie
Vice President of Sales
Durham, NC
Confidential
Aesthetic Surgical Rep -Allergan Aesthetics, Richmond/Virginia Beach, VA
Richmond, VA, 23234
AbbVie, Inc
Generic Pharmaceuticals Inside Sales Representative
Cincinnati, OH, 45201
BluPax Pharma
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information